| Company Profile |  | 0-9 | | A | | B | | C | | D | | E | | F | | G | | H | | I | | J | | K | | L | | M | | N | | O | | P | | Q | | R | | S | | T | | U | | V | | W | | X | | Y | | Z |
Program Information Company Profile Company Market News Interactive Charting Company Financials Company Calendar of Events DR Program News/Events Company Books Close / Open Notices Company Capital Raisings Company Certification Papers Company Corporate Actions Company Dividends / GDN Interest Payments Company DSF Notices Shareholder Information Estimated Fee Calculator
Company Market News
|
WPP plc
(NYSE: WPP)
|
8:00 PM UTC, 04/22/25 | |||
|---|---|---|---|---|
| Last: $36.04 | Change: +0.86 | %Change: +2.44% | Volume: 280,822 | |
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading
Back
Last updated: 11/14/2024 10:59:57 AM
Back
Last updated: 11/14/2024 10:59:57 AM
10:59 AM EST, 11/14/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were moving higher late Thursday morning, rising 0.89% to 1,323.86 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by biopharmaceutical company Grifols (GRFS) and petroleum refiner Equinor (EQNR), which rose 6% and 3.9% respectively. They were followed by lender Banco Bilbao Vizcaya Argentaria (BBVA) and biotech firm BioNTech (BNTX), which were up 2.7% and 1.7% respectively.
The decliners from continental Europe were led by biopharmaceutical companies Genfit (GNFT) and Cellectis (CLLS), which fell 9.7% and 4% respectively. They were followed by biopharmaceutical company DBV Technologies (DBVT) and medical device maker EDAP TMS (EDAP), which dropped 2.9% and 2.1% respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical company Akari Therapeutics (AKTX) and insurance provider Prudential (PUK), which increased 7.1% and 2.5% respectively. They were followed by communications company WPP (WPP) and cruise line operator Carnival (CUK), which rose 1.6% and 1.4% respectively.
The decliners from the UK and Ireland were led by biopharmaceutical company Adaptimmune Therapeutics (ADAP) and biotech firm Trinity Biotech (TRIB), which tumbled 13% and 10% respectively. They were followed by software firm Endava (DAVA) and biopharmaceutical company Amarin (AMRN), which lost 4.4% and 3.9% respectively.
http://www.mtnewswires.com
Copyright © 2024 MT Newswires. All rights reserved. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.
